Tirabrutinib
Tirabrutinib (GS-4059/ONO-4059) is an orally bioavailable, covalent Bruton's Tyrosine Kinase (BTK) inhibitor (IC50 = 6.8 nM) capable of crossing the blood-brain barrier. It suppresses aberrant B-cell receptor signaling and is utilized in research for B-cell malignancies like Waldenström's macroglobulinemia and autoimmune disorders, with applications in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
1351636-18-4
Product Name Alternative
Tirabrutinib, Velexbru, ONO 4059, ONO4059, ONO-4059, GS4059, GS-4059, GS 4059, BTK
Field of Research
Cardiovascular Research, Cell Biology, Signal Transduction
Purity
99.64% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (7.26 mM) ; DMSO:90 mg/mL (198.03 mM)
Smiles
CC#CC (=O) N1CC[C@H] (C1) n1c2ncnc (N) c2n (-c2ccc (Oc3ccccc3) cc2) c1=O
Molecular Formula
C25H22N6O3
Molecular Weight
454.48
Storage Conditions
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Plasma Cell Marker (LIV3G11, same as 7B18), CF640R conjugate, 0.1mg/mL
Cytochrome C (CTC05), CF740 conjugate, 0.1mg/mL
![Elab Fluor® 488 Anti-Mouse CD22 Antibody[Cy34.1]](https://cdn.genprice.uk/products/763/68dd1499061270361e7ceb70/imageurl/e-ab-f1021ul.webp)